Drupal.behaviors.print = function(context) {window.print();window.close();}>
WUSTL, ICR to Use $4M Komen Grant to Develop Breast Cancer Dx, Screen Treatments
June 04, 2012
WUSTL, ICR to Use $4M Komen Grant to Develop Breast Cancer Dx, Screen Treatments
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Sequencing Studies Lead to New Clinical Trial for Overlooked HER2 Mutations in Breast Cancer
December 12, 2012 / Clinical Sequencing News
Dutch Researchers Head SU2C Tumor Profiling Study
August 3, 2012 / GenomeWeb Daily News
WGS IDs Markers of Response to Aromatase Inhibitors; New Trial Will Use Signatures to Guide Treatment
June 13, 2012 / Clinical Sequencing News
Wash U Team Finds Genomic Profile May Predict Aromatase Inhibitor Response in Breast Cancer Patients
June 11, 2012 / GenomeWeb Daily News
Genomic Health Inks PGx Alliance with OncoMed
May 2, 2012 / GenomeWeb Daily News